Publications

Erichsen R, Kelsh MA, Oliner KS, Nielsen KB, Frøslev T, Lænkholm AV, et al. Prognostic impact of tumor MET expression among patients with stage IV gastric cancer: A Danish cohort study. Presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Taipei, Taiwan, October 28–30, 2014.

Meddings J, Reichert H, McMahon LF. 2014. Challenges and proposed improvements for reviewing symptoms and catheter use to identify National Healthcare Safety Network catheter-associated urinary tract infections. Am J Infect Cont 42(10):S236-S241; doi: 10.1016/j.ajic.2014.05.024. PMID: 25239716.

Meddings J, Saint S, Krein S, Gaies E, Reichert H, Hickner A, McNamara S, Mody L. Systematic review of interventions to reduce catheter-associated urinary tract infection in the long-term care setting. Presented at ID Week, Philadelphia, PA, October 2014.

Greene T, Kiyoshi-Teo H, Reichert H, Krein S, Saint S. 2014. Urinary catheter indications in the United States: Results from a national survey of acute care hospitals. Infect Contr Hosp Epidemiol 35(Sup 3):S96-S98; doi: 10.1086/677823. PMID: 25222904.

Movva N, Babik I, Galloway JC, Lobo MA. Use of an innovative rehabilitation device for infants to improve upper extremity functionality. Poster presentation at the Undergraduate Research and Service Celebratory Symposium, Newark, DE, August 2014.

Jensen IS, Bay C, Cyr PL. Estimating the impact of combining cangrelor and bivalirudin to a U.S. hospital performing PCI procedures. ISPOR 18^th Annual International Meeting, New Montreal Quebec, 2014.

Jensen IS, Wu C, Bay CB, Cyr PL. Estimating the clinical value of cangrelor in patients undergoing PCI. International Academy of Cardiology, 19th World Congress on Heart Disease, Boston, MA, 2014.

Wu C, Fortier K, Fan WJ, LePensse K, Bay CB, Cyr PL, Jensen IS. A U.S. hospital budget impact model for oritivancin in ABSSSI patients with risk of MRSA infections. ISPOR 16^th Annual European Congress, Amsterdam, Netherlands, 2014.

Bay C, Cyr PL, Jensen IS. Estimating the value of cangrelor from eliminating preloading in coronary artery bypass graft (CABG) patients. ISPOR 16th Annual European Congress, Amsterdam, Netherlands, 2014.

Pinto DS, Nicholson G, Harrington RA, Cyr PL, Bhatt DL. CHAMPION PHOENIX Study economic results: Direct hospitalization costs of patients receiving clopidogrel or cangralor during percutaneous coronary intervention. American Heart Association QCOR conference, Baltimore, MD, 2014.